Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SwitchDMO
NCT01787669Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Jun 2013
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, dexamethasone in diabetic macular edema (DME), sponsored by University of Sydney. Started Jun 2013; status: completed.
02
Drugs
bevacizumabdexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01787669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787669.